[1]韩效林,李敬东,王婉玲,等.骨髓增生异常综合征患者外周血单个核细胞中视网膜母细胞瘤蛋白结合锌指结构基因1的表达[J].新乡医学院学报,2017,34(3):166-169.[doi:10.7683/xxyxyxb.2017.03.002]
　HAN Xiao-lin,LI Jing-dong,WANG Wan-ling,et al.Expression of retinoblastoma protein-interacting zinc finger gene 1 in peripheral blood mononuclear cell of patients with myelodysplastic syndrome[J].Journal of Xinxiang Medical University,2017,34(3):166-169.[doi:10.7683/xxyxyxb.2017.03.002]
点击复制

骨髓增生异常综合征患者外周血单个核细胞中视网膜母细胞瘤蛋白结合锌指结构基因1的表达
分享到：

《新乡医学院学报》[ISSN:1004-7239/CN:41-1186/R]

卷:
34
期数:
2017年3
页码:
166-169
栏目:
基础研究
出版日期:
2017-03-05

文章信息/Info

Title:
Expression of retinoblastoma protein-interacting zinc finger gene 1 in peripheral blood mononuclear cell of patients with myelodysplastic syndrome
作者:
韩效林; 李敬东; 王婉玲; 杨　翠; 郜振兴
（新乡医学院第一附属医院血液二科，河南　卫辉　453100）
Author(s):
HAN Xiao-lin; LI Jing-dong; WANG Wan-ling; YANG Cui; GAO Zhen-xing
（Department of Hematology，the First Affiliated Hospital of Xinxiang Medical University，Weihui 453100，Henan Province，China）
关键词:
视网膜母细胞瘤蛋白结合锌指结构基因1; 骨髓增生异常综合征; 外周血单个核细胞
Keywords:
retinoblastoma protein-interacting zinc finger gene 1; myelodysplastic syndrome; peripheral blood mononuclear cell
分类号:
R733；R551.3
DOI:
10.7683/xxyxyxb.2017.03.002
文献标志码:
A
摘要:
目的　探讨骨髓增生异常综合征（MDS）患者外周血单个核细胞（PBMC）中视网膜母细胞瘤蛋白结合锌指结构基因1（RIZ1）的表达及其临床意义。方法　选取2012年7月至2015年7月于新乡医学院第一附属医院收治的MDS患者86例为研究对象（MDS组），并选取同期体检健康者90例作为对照组，采用实时荧光定量聚合酶链反应和Western blot法检测PBMC中RIZ1蛋白及其mRNA表达水平，并分析RIZ1表达与MDS患者临床病理特征的关系。结果　对照组和MDS组受试者PBMC中RIZ1 mRNA表达水平分别为1.73±0.41和0.47±0.18，MDS组患者PBMC中RIZ1 mRNA表达水平显著低于对照组（P<0.05）。对照组和MDS组受试者PBMC中RIZ1蛋白表达水平分别为1.32±0.36和0.35±0.22，MDS组患者PBMC中RIZ1蛋白表达水平显著低于对照组（P<0.05）。RIZ1蛋白表达与MDS患者的年龄、性别、白细胞计数、血红蛋白水平及血小板计数无关（P>0.05），而与骨髓原始细胞比例、世界卫生组织（WHO）分型及染色体核型有关（P<0.05）。结论　RIZ1在MDS患者PBMC中呈低水平表达，并与患者的骨髓原始细胞比例、WHO分型及染色体核型显著相关，这为MDS的早期诊断和靶向治疗提供了新的思路。
Abstract:
Objective　To investigate the clinical significance of the expression of retinoblastoma protein-interacting zinc finger gene 1（RIZ1） in peripheral blood mononuclear cell（PBMC） of patients with myelodysplastic syndrome（MDS）.Methods　Eighty-six patients with MDS in the First Affiliated Hospital of Xinxiang Medical University from July 2012 to July 2015 were selected as MDS group，and ninety healthy subjects were selected as control group.The expressions of RIZ1 protein and mRNA in PBMC were detected by real time fluorescence quantitative polymerase chain reaction and Western blot，and the relationship between RIZ1 expression and clinicopathological features of MDS patients was analyzed.Results　The expression of RIZ1 mRNA in PBMC in the control group and MDS group was 1.73±0.41 and 0.47±0.18，respectively；the expression of RIZ1 mRNA in PBMC in the MDS group was significantly lower than that in the control group（P<0.05）.The expression of RIZ1 protein in PBMC in the control group and MDS group was 1.32±0.36 and 0.35±0.22，respectively；the expression of RIZ1 protein in PBMC in the MDS group was significantly lower than that in the control group（P<0.05）.The expression of RIZ1 protein was not associated with age，sex，white blood cell count，hemoglobin level and platelet count in patients with MDS（P>0.05）；but it was significantly correlated to the proportion of bone marrow progenitor cells，world health organization（WHO） typing and chromosome karyotype（P<0.05）.Conclusion　The expression of RIZ1 decreases in PBMC of MDS patients，and the expression of RIZ1 is significantly correlated to the proportion of bone marrow progenitor cells，WHO typing and chromosome karyotype；which provides a new way for early diagnosis and targeted therapy of MDS.

参考文献/References:

［1］　BALL B，ZEIDAN A，GORE S D，et al.Hypomethylating agent combination strategies in myelodysplastic syndromes：hopes and shortcomings［J］.Leuk Lymphoma，2017，58（5）：1022-1036.
［2］　KIM C K，HAN D H，JI Y S，et al.Biomarkers of angiogenesis as prognostic factors in myelodysplastic syndrome patients treated with hypomethylating agents［J］.Leuk Res，2016，40（11）：21-28.
［3］　GIRALT S.Allogeneic hematopoietic cell transplantation for myelodysplastic syndromes：where are we going with this［J］.J Oncol Pract，2016，12（9）：793-794.
［4］　BHATT V R，STEENSMA D P.Hematopoietic cell transplantation for myelodysplastic syndromes［J］.J Oncol Pract，2016，12（9）：786-792.
［5］　DONG S W，ZHANG H，WANG B L，et al.Effect of the downregulation of SMYD3 expression by RNAi on RIZ1 expression and proliferation of esophageal squamous cell carcinoma［J］.Oncol Rep，2014，32（3）：1064-1070.
［6］　CHEEDIPUDI S，PURI D，SALEH A，et al.A fine balance：epigenetic control of cellular quiescence by the tumor suppressor PRDM2/RIZ at a bivalent domain in the cyclin a gene［J］.Nucleic Acids Res，2015，43（13）：6236-6256.
［7］　XIE X，MAN X，ZHU Z，et al.Tumor suppressor RIZ1 in obesity and the PI3K/AKT/mTOR pathway［J］.Obesity，2016，24（2）：389-397.
［8］　肖志坚.骨髓增生异常综合征的精确诊断［J］.中华血液学杂志，2015，36（5）：361-362.
［9］　FONT P.Myelodysplastic syndrome after breast cancer.The challenge of late complications in long-term survivors［J］.Leuk Res，2016，40（10）：88-89.
［10］　林巍，张莉，廉红云，等.儿童骨髓增生异常综合征12例［J］.中华实用儿科临床杂志，2015，30（3）：194-197.
［11］　NAKAJIMA H.Application of iPS cells derived from congenital myelodysplastic syndrome for research of nomal hematopoesis and hematological malignancies［J］.Rinsho Ketsueki，2016，57（8）：1087-1094.
［12］　TSUKAMOTO Y，KIYASU J，UTSUNOMIYA H，et al.Danazol-induced peliosis hepatis accompanied by disseminated intravascular coagulation in a patient with myelodysplastic syndrome transformed from aplastic anemia［J］.Rinsho Ketsueki，2016，57（8）：1026-1031.
［13］　DING M H，WANG Z，JIANG L，et al.The transducible TAT-RIZ1-PR protein exerts histone methyltransferase activity and tumor-suppressive functions in human malignant meningiomas［J］.Biomaterials，2015，56：165-178.
［14］　CONGDON L M，SIMS J K，TUZON C T，et al.The PR-Set7 binding domain of RIZ1 is required for the H4K20me1-H3K9me1 trans-tail ’histone code’ and RIZ1 tumor suppressor function［J］.Nucleic Acids Res，2014，42（6）：3580-3589.
［15］　DONG S，ZHANG P，LIANG S，et al.The role of the retinoblastoma protein-interacting zinc finger gene 1 tumor suppressor gene in human esophageal squamous cell carcinoma cells［J］.Oncol Lett，2013，6（6）：1656-1662.
［16］　CHEN Y，ZHANG P，WANG Y，et al.Construction of PR domain eukaryotic expression vector and its inhibitory effect on esophageal cancer cells［J］.Chin J Cancer Res，2013，25（5）：493-499.
［17］　YANG C M，SHINKAI Y.Prdm12 is induced by retinoic acid and exhibits anti-proliferative properties through the cell cycle modulation of P19 embryonic carcinoma cells［J］.Cell Struct Funct，2013，38（2）：197-206.
［18］　DONG S W，ZHANG Y W，CHEN Y，et al.PRDI-BF1-RIZ domain of retinoblastoma protein-interacting zinc finger gene 1 induces apoptosis and exerts anticancer activity in esophageal squamous cell carcinoma cells［J］.Oncol Lett，2015，9（1）：341-346.
［19］　LIU Z Y，WANG J Y，LIU H H，et al.Retinoblastoma protein-interacting zinc-finger gene 1 （RIZ1） dysregulation in human malignant meningiomas［J］.Oncogene，2013，32（10）：1216-1222.
［20］　DU Y，CARLING T，FANG W，et al.Hypermethylation in human cancers of the RIZ1 tumor suppressor gene，a member of a histone/protein methylt ransferase superfamily［J］.Cancer Res，2001，61（22）：8094-8099.

相似文献/References:

[1]赵媛英,贺立山,李志英,等.骨髓增生异常综合征30例分析[J].新乡医学院学报,1991,8(04):280.

更新日期/Last Update: 2017-03-05